Dose adherence and baseline exposure analysis of the ibrutinib 420 mg dose administered to patients with previously treated chronic lymphocytic leukemia (CLL).

Paul M. Barr; Jennifer R. Brown; Peter Hillmen; Susan O’Brien; Jacqueline C. Barrientos; Nishitha Reddy; Steven Coutré; Stephen P. Mulligan; Ulrich Jäger; Richard R. Furman

doi:10.1200/jco.2015.33.15_suppl.7012

Dose adherence and baseline exposure analysis of the ibrutinib 420 mg dose administered to patients with previously treated chronic lymphocytic leukemia (CLL).

Identifier:nobleid.org/w1/20260515/27CF6CD9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/27CF6CD9.svg?ark=w1%2F20260515%2F27CF6CD9)](https://nobleid.org/work/w1/20260515/27CF6CD9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Jacqueline C. Barrientos

Claim authorship of this work

Dose adherence and baseline exposure analysis of the ibrutinib 420 mg dose administered to patients with previously treated chronic lymphocytic leukemia (CLL).

Identifier:nobleid.org/w1/20260515/27CF6CD9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/27CF6CD9.svg?ark=w1%2F20260515%2F27CF6CD9)](https://nobleid.org/work/w1/20260515/27CF6CD9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Jacqueline C. Barrientos

Claim authorship of this work